LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

<
<<
Previous
Page 1 of 497
Next
>>
>
1 to 25 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
MCF7	XMD11-85h	0.04	uM	LJP6	1	P24	72	hr	1235	3145	4156	0.7567	0.6538
MCF7	Trametinib	0.04	uM	LJP5	2	P24	72	hr	1235	2085	4156	0.5017	0.2909
MCF 10A	Trametinib	0.04	uM	LJP5	1	P24	72	hr	513	626	10401	0.0602	0.0114
MCF 10A	Trametinib	0.04	uM	LJP5	3	P24	72	hr	513	723	10401	0.0695	0.0212
MCF7	XMD11-85h	0.04	uM	LJP6	3	P24	72	hr	1235	3335	4156	0.8024	0.7189
MCF7	Trametinib	0.04	uM	LJP5	1	P24	72	hr	1235	2020	4156	0.4860	0.2686
Hs 578T	XMD11-85h	0.04	uM	LJP6	2	P24	72	hr	929	3135	3228	0.9712	0.9595
MCF 10A	XMD11-85h	0.04	uM	LJP6	3	P24	72	hr	513	8960	10401	0.8614	0.8543
Hs 578T	Trametinib	0.04	uM	LJP5	3	P24	72	hr	929	1586	3228	0.4913	0.2857
MCF 10A	Trametinib	0.04	uM	LJP5	2	P24	72	hr	513	677	10401	0.0651	0.0165
MCF7	XMD11-85h	0.04	uM	LJP6	2	P24	72	hr	1235	3477	4156	0.8366	0.7675
BT-20	XMD11-85h	0.04	uM	LJP6	2	P24	72	hr	1657	4578	5505	0.8315	0.7589
Hs 578T	Trametinib	0.04	uM	LJP5	2	P24	72	hr	929	1472	3228	0.4560	0.2361
BT-20	Trametinib	0.04	uM	LJP5	3	P24	72	hr	1657	3889	5505	0.7064	0.5799
BT-20	XMD11-85h	0.04	uM	LJP6	3	P24	72	hr	1657	4599	5505	0.8353	0.7644
BT-20	Trametinib	0.04	uM	LJP5	2	P24	72	hr	1657	4134	5505	0.7509	0.6435
MCF 10A	XMD11-85h	0.04	uM	LJP6	1	P24	72	hr	513	8708	10401	0.8372	0.8288
MCF 10A	XMD11-85h	0.04	uM	LJP6	2	P24	72	hr	513	9442	10401	0.9078	0.9030
BT-20	Trametinib	0.04	uM	LJP5	1	P24	72	hr	1657	4104	5505	0.7454	0.6357
Hs 578T	XMD11-85h	0.04	uM	LJP6	1	P24	72	hr	929	3247	3228	1.0059	1.0082
Hs 578T	Trametinib	0.04	uM	LJP5	1	P24	72	hr	929	1519	3228	0.4706	0.2566
Hs 578T	XMD11-85h	0.04	uM	LJP6	3	P24	72	hr	929	3164	3228	0.9802	0.9721
BT-20	XMD11-85h	0.04	uM	LJP6	1	P24	72	hr	1657	4715	5505	0.8564	0.7945
MDA-MB-231	XMD11-85h	0.04	uM	LJP6	1	P24	72	hr	868	2813	3486	0.8069	0.7428
MCF7	Trametinib	0.04	uM	LJP5	3	P24	72	hr	1235	2081	4156	0.5007	0.2895

<
<<
Previous
Page 1 of 497
Next
>>
>
1 to 25 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)